nodes	percent_of_prediction	percent_of_DWPC	metapath
Betaxolol—CYP1A2—Thalidomide—leprosy	0.306	0.508	CbGbCtD
Betaxolol—CYP1A2—Rifampicin—leprosy	0.297	0.492	CbGbCtD
Betaxolol—Arterial thrombosis—Thalidomide—leprosy	0.0123	0.031	CcSEcCtD
Betaxolol—Lacrimal disorder—Thalidomide—leprosy	0.00741	0.0186	CcSEcCtD
Betaxolol—Proteinuria—Dapsone—leprosy	0.00736	0.0185	CcSEcCtD
Betaxolol—Protein urine present—Dapsone—leprosy	0.00726	0.0183	CcSEcCtD
Betaxolol—Lactic dehydrogenase activity increased—Thalidomide—leprosy	0.00647	0.0163	CcSEcCtD
Betaxolol—Blood lactate dehydrogenase increased—Thalidomide—leprosy	0.0057	0.0143	CcSEcCtD
Betaxolol—Psoriasis—Thalidomide—leprosy	0.00527	0.0133	CcSEcCtD
Betaxolol—Hypothyroidism—Thalidomide—leprosy	0.00516	0.013	CcSEcCtD
Betaxolol—Menstrual disorder—Thalidomide—leprosy	0.00486	0.0122	CcSEcCtD
Betaxolol—Neuralgia—Thalidomide—leprosy	0.00477	0.012	CcSEcCtD
Betaxolol—Thrombosis—Thalidomide—leprosy	0.00468	0.0118	CcSEcCtD
Betaxolol—Hyperlipidaemia—Thalidomide—leprosy	0.00459	0.0116	CcSEcCtD
Betaxolol—Psychotic disorder—Dapsone—leprosy	0.00459	0.0115	CcSEcCtD
Betaxolol—Stupor—Thalidomide—leprosy	0.00444	0.0112	CcSEcCtD
Betaxolol—Nasopharyngitis—Dapsone—leprosy	0.0042	0.0106	CcSEcCtD
Betaxolol—Influenza—Dapsone—leprosy	0.00406	0.0102	CcSEcCtD
Betaxolol—Numbness—Thalidomide—leprosy	0.00399	0.0101	CcSEcCtD
Betaxolol—Sensory loss—Thalidomide—leprosy	0.00382	0.00962	CcSEcCtD
Betaxolol—Proteinuria—Thalidomide—leprosy	0.00377	0.00949	CcSEcCtD
Betaxolol—Accidental injury—Thalidomide—leprosy	0.00374	0.00942	CcSEcCtD
Betaxolol—Protein urine present—Thalidomide—leprosy	0.00372	0.00936	CcSEcCtD
Betaxolol—Arthropathy—Thalidomide—leprosy	0.00364	0.00917	CcSEcCtD
Betaxolol—Thinking abnormal—Thalidomide—leprosy	0.00362	0.00911	CcSEcCtD
Betaxolol—Oliguria—Thalidomide—leprosy	0.00359	0.00905	CcSEcCtD
Betaxolol—Hyperuricaemia—Thalidomide—leprosy	0.00357	0.00899	CcSEcCtD
Betaxolol—Neuropathy peripheral—Dapsone—leprosy	0.00355	0.00893	CcSEcCtD
Betaxolol—Leukocytosis—Thalidomide—leprosy	0.00352	0.00887	CcSEcCtD
Betaxolol—Hypercholesterolaemia—Thalidomide—leprosy	0.0035	0.00881	CcSEcCtD
Betaxolol—Atrioventricular block—Thalidomide—leprosy	0.00341	0.00859	CcSEcCtD
Betaxolol—Sinusitis—Dapsone—leprosy	0.0034	0.00855	CcSEcCtD
Betaxolol—Blood uric acid increased—Thalidomide—leprosy	0.00337	0.00849	CcSEcCtD
Betaxolol—Neck pain—Thalidomide—leprosy	0.00335	0.00844	CcSEcCtD
Betaxolol—Hyperkalaemia—Thalidomide—leprosy	0.00325	0.00819	CcSEcCtD
Betaxolol—Pharyngitis—Dapsone—leprosy	0.00322	0.00812	CcSEcCtD
Betaxolol—Depressed level of consciousness—Thalidomide—leprosy	0.0032	0.00805	CcSEcCtD
Betaxolol—Neuropathy—Thalidomide—leprosy	0.00311	0.00783	CcSEcCtD
Betaxolol—Dry eye—Thalidomide—leprosy	0.00306	0.0077	CcSEcCtD
Betaxolol—Cramps of lower extremities—Thalidomide—leprosy	0.00304	0.00766	CcSEcCtD
Betaxolol—Tinnitus—Dapsone—leprosy	0.00303	0.00762	CcSEcCtD
Betaxolol—Hypertonia—Thalidomide—leprosy	0.0029	0.00731	CcSEcCtD
Betaxolol—Mental disability—Thalidomide—leprosy	0.00287	0.00723	CcSEcCtD
Betaxolol—Erythema—Dapsone—leprosy	0.00283	0.00712	CcSEcCtD
Betaxolol—Lymphadenopathy—Thalidomide—leprosy	0.00282	0.00709	CcSEcCtD
Betaxolol—Thrombophlebitis—Thalidomide—leprosy	0.00278	0.00699	CcSEcCtD
Betaxolol—Diabetes mellitus—Thalidomide—leprosy	0.00276	0.00696	CcSEcCtD
Betaxolol—Deafness—Thalidomide—leprosy	0.00269	0.00676	CcSEcCtD
Betaxolol—Vascular purpura—Thalidomide—leprosy	0.00269	0.00676	CcSEcCtD
Betaxolol—Eczema—Thalidomide—leprosy	0.00268	0.00673	CcSEcCtD
Betaxolol—Vision blurred—Dapsone—leprosy	0.00267	0.00671	CcSEcCtD
Betaxolol—Eye pain—Thalidomide—leprosy	0.00266	0.0067	CcSEcCtD
Betaxolol—Injury—Thalidomide—leprosy	0.00262	0.00658	CcSEcCtD
Betaxolol—Libido decreased—Thalidomide—leprosy	0.00259	0.00653	CcSEcCtD
Betaxolol—Amnesia—Thalidomide—leprosy	0.00256	0.00644	CcSEcCtD
Betaxolol—Increased appetite—Thalidomide—leprosy	0.00256	0.00644	CcSEcCtD
Betaxolol—Vertigo—Dapsone—leprosy	0.00254	0.0064	CcSEcCtD
Betaxolol—Purpura—Thalidomide—leprosy	0.00249	0.00628	CcSEcCtD
Betaxolol—Arthritis—Thalidomide—leprosy	0.00247	0.00623	CcSEcCtD
Betaxolol—Cough—Dapsone—leprosy	0.00247	0.00621	CcSEcCtD
Betaxolol—Cardiac failure—Thalidomide—leprosy	0.00246	0.0062	CcSEcCtD
Betaxolol—Hypoglycaemia—Thalidomide—leprosy	0.00246	0.0062	CcSEcCtD
Betaxolol—Lethargy—Thalidomide—leprosy	0.00245	0.00617	CcSEcCtD
Betaxolol—Osteoarthritis—Thalidomide—leprosy	0.0024	0.00605	CcSEcCtD
Betaxolol—Disturbance in sexual arousal—Thalidomide—leprosy	0.00238	0.006	CcSEcCtD
Betaxolol—Affect lability—Thalidomide—leprosy	0.00237	0.00596	CcSEcCtD
Betaxolol—Psychotic disorder—Thalidomide—leprosy	0.00235	0.00591	CcSEcCtD
Betaxolol—Mood swings—Thalidomide—leprosy	0.00228	0.00573	CcSEcCtD
Betaxolol—Ataxia—Thalidomide—leprosy	0.00226	0.00569	CcSEcCtD
Betaxolol—Tachycardia—Dapsone—leprosy	0.00225	0.00567	CcSEcCtD
Betaxolol—Hypokalaemia—Thalidomide—leprosy	0.00219	0.00551	CcSEcCtD
Betaxolol—Breast disorder—Thalidomide—leprosy	0.00217	0.00547	CcSEcCtD
Betaxolol—Aspartate aminotransferase increased—Thalidomide—leprosy	0.00216	0.00545	CcSEcCtD
Betaxolol—Toxic epidermal necrolysis—Thalidomide—leprosy	0.00216	0.00545	CcSEcCtD
Betaxolol—Cramp muscle—Thalidomide—leprosy	0.00216	0.00545	CcSEcCtD
Betaxolol—Alanine aminotransferase increased—Thalidomide—leprosy	0.00212	0.00534	CcSEcCtD
Betaxolol—Insomnia—Dapsone—leprosy	0.00209	0.00525	CcSEcCtD
Betaxolol—Influenza—Thalidomide—leprosy	0.00208	0.00523	CcSEcCtD
Betaxolol—Dysphagia—Thalidomide—leprosy	0.00208	0.00523	CcSEcCtD
Betaxolol—Bronchospasm—Thalidomide—leprosy	0.00204	0.00514	CcSEcCtD
Betaxolol—Angina pectoris—Thalidomide—leprosy	0.00202	0.00509	CcSEcCtD
Betaxolol—Bronchitis—Thalidomide—leprosy	0.002	0.00503	CcSEcCtD
Betaxolol—Upper respiratory tract infection—Thalidomide—leprosy	0.00193	0.00486	CcSEcCtD
Betaxolol—Erectile dysfunction—Thalidomide—leprosy	0.00191	0.00482	CcSEcCtD
Betaxolol—Weight increased—Thalidomide—leprosy	0.00189	0.00476	CcSEcCtD
Betaxolol—Weight decreased—Thalidomide—leprosy	0.00188	0.00473	CcSEcCtD
Betaxolol—Hyperglycaemia—Thalidomide—leprosy	0.00187	0.00472	CcSEcCtD
Betaxolol—Pneumonia—Thalidomide—leprosy	0.00186	0.00469	CcSEcCtD
Betaxolol—Infestation NOS—Thalidomide—leprosy	0.00185	0.00466	CcSEcCtD
Betaxolol—Infestation—Thalidomide—leprosy	0.00185	0.00466	CcSEcCtD
Betaxolol—Depression—Thalidomide—leprosy	0.00185	0.00465	CcSEcCtD
Betaxolol—Acute coronary syndrome—Thalidomide—leprosy	0.00183	0.0046	CcSEcCtD
Betaxolol—Body temperature increased—Dapsone—leprosy	0.00182	0.00459	CcSEcCtD
Betaxolol—Neuropathy peripheral—Thalidomide—leprosy	0.00182	0.00457	CcSEcCtD
Betaxolol—Myocardial infarction—Thalidomide—leprosy	0.00182	0.00457	CcSEcCtD
Betaxolol—Stomatitis—Thalidomide—leprosy	0.00181	0.00455	CcSEcCtD
Betaxolol—Conjunctivitis—Thalidomide—leprosy	0.0018	0.00453	CcSEcCtD
Betaxolol—Sweating—Thalidomide—leprosy	0.00178	0.00447	CcSEcCtD
Betaxolol—Epistaxis—Thalidomide—leprosy	0.00175	0.0044	CcSEcCtD
Betaxolol—Sinusitis—Thalidomide—leprosy	0.00174	0.00437	CcSEcCtD
Betaxolol—Agranulocytosis—Thalidomide—leprosy	0.00173	0.00435	CcSEcCtD
Betaxolol—Bradycardia—Thalidomide—leprosy	0.00169	0.00426	CcSEcCtD
Betaxolol—Rhinitis—Thalidomide—leprosy	0.00167	0.0042	CcSEcCtD
Betaxolol—Hypoaesthesia—Thalidomide—leprosy	0.00165	0.00417	CcSEcCtD
Betaxolol—Pharyngitis—Thalidomide—leprosy	0.00165	0.00415	CcSEcCtD
Betaxolol—Visual impairment—Thalidomide—leprosy	0.0016	0.00403	CcSEcCtD
Betaxolol—Eye disorder—Thalidomide—leprosy	0.00155	0.00391	CcSEcCtD
Betaxolol—Tinnitus—Thalidomide—leprosy	0.00155	0.0039	CcSEcCtD
Betaxolol—Cardiac disorder—Thalidomide—leprosy	0.00154	0.00388	CcSEcCtD
Betaxolol—Angiopathy—Thalidomide—leprosy	0.00151	0.0038	CcSEcCtD
Betaxolol—Immune system disorder—Thalidomide—leprosy	0.0015	0.00378	CcSEcCtD
Betaxolol—Mediastinal disorder—Thalidomide—leprosy	0.0015	0.00377	CcSEcCtD
Betaxolol—Chills—Thalidomide—leprosy	0.00149	0.00376	CcSEcCtD
Betaxolol—Arrhythmia—Thalidomide—leprosy	0.00149	0.00374	CcSEcCtD
Betaxolol—Alopecia—Thalidomide—leprosy	0.00147	0.0037	CcSEcCtD
Betaxolol—Vomiting—Dapsone—leprosy	0.00147	0.00369	CcSEcCtD
Betaxolol—Mental disorder—Thalidomide—leprosy	0.00146	0.00367	CcSEcCtD
Betaxolol—Malnutrition—Thalidomide—leprosy	0.00145	0.00364	CcSEcCtD
Betaxolol—Headache—Dapsone—leprosy	0.00145	0.00364	CcSEcCtD
Betaxolol—Tension—Thalidomide—leprosy	0.00142	0.00358	CcSEcCtD
Betaxolol—Dysgeusia—Thalidomide—leprosy	0.00142	0.00357	CcSEcCtD
Betaxolol—Nervousness—Thalidomide—leprosy	0.00141	0.00354	CcSEcCtD
Betaxolol—Muscle spasms—Thalidomide—leprosy	0.00139	0.0035	CcSEcCtD
Betaxolol—Nausea—Dapsone—leprosy	0.00137	0.00345	CcSEcCtD
Betaxolol—Vision blurred—Thalidomide—leprosy	0.00136	0.00343	CcSEcCtD
Betaxolol—Tremor—Thalidomide—leprosy	0.00136	0.00341	CcSEcCtD
Betaxolol—Ill-defined disorder—Thalidomide—leprosy	0.00134	0.00338	CcSEcCtD
Betaxolol—Anaemia—Thalidomide—leprosy	0.00134	0.00337	CcSEcCtD
Betaxolol—Malaise—Thalidomide—leprosy	0.00131	0.00329	CcSEcCtD
Betaxolol—Vertigo—Thalidomide—leprosy	0.0013	0.00327	CcSEcCtD
Betaxolol—Syncope—Thalidomide—leprosy	0.0013	0.00327	CcSEcCtD
Betaxolol—Palpitations—Thalidomide—leprosy	0.00128	0.00322	CcSEcCtD
Betaxolol—Loss of consciousness—Thalidomide—leprosy	0.00127	0.0032	CcSEcCtD
Betaxolol—Cough—Thalidomide—leprosy	0.00126	0.00318	CcSEcCtD
Betaxolol—Arthralgia—Thalidomide—leprosy	0.00123	0.0031	CcSEcCtD
Betaxolol—Chest pain—Thalidomide—leprosy	0.00123	0.0031	CcSEcCtD
Betaxolol—Myalgia—Thalidomide—leprosy	0.00123	0.0031	CcSEcCtD
Betaxolol—Anxiety—Thalidomide—leprosy	0.00123	0.00309	CcSEcCtD
Betaxolol—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.00122	0.00308	CcSEcCtD
Betaxolol—Discomfort—Thalidomide—leprosy	0.00122	0.00307	CcSEcCtD
Betaxolol—Dry mouth—Thalidomide—leprosy	0.00121	0.00303	CcSEcCtD
Betaxolol—Confusional state—Thalidomide—leprosy	0.00119	0.003	CcSEcCtD
Betaxolol—Oedema—Thalidomide—leprosy	0.00118	0.00297	CcSEcCtD
Betaxolol—Infection—Thalidomide—leprosy	0.00117	0.00295	CcSEcCtD
Betaxolol—Shock—Thalidomide—leprosy	0.00116	0.00293	CcSEcCtD
Betaxolol—Nervous system disorder—Thalidomide—leprosy	0.00116	0.00292	CcSEcCtD
Betaxolol—Thrombocytopenia—Thalidomide—leprosy	0.00116	0.00291	CcSEcCtD
Betaxolol—Tachycardia—Thalidomide—leprosy	0.00115	0.0029	CcSEcCtD
Betaxolol—Skin disorder—Thalidomide—leprosy	0.00115	0.00289	CcSEcCtD
Betaxolol—Hyperhidrosis—Thalidomide—leprosy	0.00114	0.00288	CcSEcCtD
Betaxolol—Anorexia—Thalidomide—leprosy	0.00113	0.00283	CcSEcCtD
Betaxolol—Hypotension—Thalidomide—leprosy	0.0011	0.00278	CcSEcCtD
Betaxolol—Musculoskeletal discomfort—Thalidomide—leprosy	0.00108	0.00271	CcSEcCtD
Betaxolol—Insomnia—Thalidomide—leprosy	0.00107	0.00269	CcSEcCtD
Betaxolol—Paraesthesia—Thalidomide—leprosy	0.00106	0.00267	CcSEcCtD
Betaxolol—Dyspnoea—Thalidomide—leprosy	0.00105	0.00265	CcSEcCtD
Betaxolol—Dyspepsia—Thalidomide—leprosy	0.00104	0.00262	CcSEcCtD
Betaxolol—Decreased appetite—Thalidomide—leprosy	0.00103	0.00259	CcSEcCtD
Betaxolol—Gastrointestinal disorder—Thalidomide—leprosy	0.00102	0.00257	CcSEcCtD
Betaxolol—Fatigue—Thalidomide—leprosy	0.00102	0.00256	CcSEcCtD
Betaxolol—Constipation—Thalidomide—leprosy	0.00101	0.00254	CcSEcCtD
Betaxolol—Pain—Thalidomide—leprosy	0.00101	0.00254	CcSEcCtD
Betaxolol—Feeling abnormal—Thalidomide—leprosy	0.000974	0.00245	CcSEcCtD
Betaxolol—Urticaria—Thalidomide—leprosy	0.000939	0.00236	CcSEcCtD
Betaxolol—Body temperature increased—Thalidomide—leprosy	0.000934	0.00235	CcSEcCtD
Betaxolol—Hypersensitivity—Thalidomide—leprosy	0.000871	0.00219	CcSEcCtD
Betaxolol—Asthenia—Thalidomide—leprosy	0.000848	0.00213	CcSEcCtD
Betaxolol—Pruritus—Thalidomide—leprosy	0.000836	0.0021	CcSEcCtD
Betaxolol—Diarrhoea—Thalidomide—leprosy	0.000808	0.00203	CcSEcCtD
Betaxolol—Dizziness—Thalidomide—leprosy	0.000781	0.00197	CcSEcCtD
Betaxolol—Vomiting—Thalidomide—leprosy	0.000751	0.00189	CcSEcCtD
Betaxolol—Rash—Thalidomide—leprosy	0.000745	0.00188	CcSEcCtD
Betaxolol—Dermatitis—Thalidomide—leprosy	0.000744	0.00187	CcSEcCtD
Betaxolol—Headache—Thalidomide—leprosy	0.00074	0.00186	CcSEcCtD
Betaxolol—Nausea—Thalidomide—leprosy	0.000702	0.00177	CcSEcCtD
